Clinical validity of the PROMIS pediatric sleep short forms in children receiving treatment for cancer.
Lauren C DanielJ Yael GrossLisa J MeltzerJamie L FlanneryChristopher B ForrestLamia P BarakatPublished in: Pediatric blood & cancer (2020)
The PROMIS SD and SRI short forms are promising measures for pediatric oncology, demonstrating strong internal consistency reliability and multiple indications of clinical validity. Although groups did not differ based on treatment variables, results suggest the need for universal screening for sleep problems during pediatric cancer treatment.